Cargando…
Identification of Variants in Primary and Recurrent Glioblastoma Using a Cancer-Specific Gene Panel and Whole Exome Sequencing
Glioblastoma (GBM) is an aggressive, malignant brain tumor typically resulting in death of the patient within one year following diagnosis; and those who survive beyond this point usually present with tumor recurrence within two years (5-year survival is 5%). The genetic heterogeneity of GBM has mad...
Autores principales: | Virk, Selene M., Gibson, Richard M., Quinones-Mateu, Miguel E., Barnholtz-Sloan, Jill S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423782/ https://www.ncbi.nlm.nih.gov/pubmed/25950952 http://dx.doi.org/10.1371/journal.pone.0124178 |
Ejemplares similares
-
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
por: Kim, Hoon, et al.
Publicado: (2015) -
Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes
por: Haug, Patricia, et al.
Publicado: (2021) -
Identification of Genetic Alterations in Rapid Progressive Glioblastoma by Use of Whole Exome Sequencing
por: Khan, Imran, et al.
Publicado: (2023) -
A SNP profiling panel for sample tracking in whole-exome sequencing studies
por: Pengelly, Reuben J, et al.
Publicado: (2013) -
Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing
por: Chen, Shasha, et al.
Publicado: (2022)